These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 28956468)
1. Non-ionic surfactant based vesicular drug delivery system for topical delivery of caffeine for treatment of cellulite: design, formulation, characterization, histological anti-cellulite activity, and pharmacokinetic evaluation. Teaima MH; Abdelhalim SA; El-Nabarawi MA; Attia DA; Helal DA Drug Dev Ind Pharm; 2018 Jan; 44(1):158-171. PubMed ID: 28956468 [TBL] [Abstract][Full Text] [Related]
2. New Insight for Enhanced Topical Targeting of Caffeine for Effective Cellulite Treatment: In Vitro Characterization, Permeation Studies, and Histological Evaluation in Rats. Fouad SA; Badr TA; Abdelbary A; Fadel M; Abdelmonem R; Jasti BR; El-Nabarawi M AAPS PharmSciTech; 2024 Oct; 25(7):237. PubMed ID: 39384727 [TBL] [Abstract][Full Text] [Related]
3. Histopathological evaluation of caffeine-loaded solid lipid nanoparticles in efficient treatment of cellulite. Hamishehkar H; Shokri J; Fallahi S; Jahangiri A; Ghanbarzadeh S; Kouhsoltani M Drug Dev Ind Pharm; 2015; 41(10):1640-6. PubMed ID: 25382163 [TBL] [Abstract][Full Text] [Related]
4. Sonophoresis mediated diffusion of caffeine loaded Transcutol® enriched cerosomes for topical management of cellulite. Albash R; Abdelbari MA; Elbesh RM; Khaleel EF; Badi RM; Eldehna WM; Elkaeed EB; El Hassab MA; Ahmed SM; Mosallam S Eur J Pharm Sci; 2024 Oct; 201():106875. PubMed ID: 39121922 [TBL] [Abstract][Full Text] [Related]
5. Transdermal Permeation of Caffeine Aided by Ionic Liquids: Potential for Enhanced Treatment of Cellulitis. Hernandes AN; Boscariol R; Balcão VM; Vila MMDC AAPS PharmSciTech; 2021 Apr; 22(3):121. PubMed ID: 33796955 [TBL] [Abstract][Full Text] [Related]
6. A double-blind evaluation of the activity of an anti-cellulite product containing retinol, caffeine, and ruscogenine by a combination of several non-invasive methods. Bertin C; Zunino H; Pittet JC; Beau P; Pineau P; Massonneau M; Robert C; Hopkins J J Cosmet Sci; 2001; 52(4):199-210. PubMed ID: 11479653 [TBL] [Abstract][Full Text] [Related]
7. A Comparison of the Penetration and Permeation of Caffeine into and through Human Epidermis after Application in Various Vesicle Formulations. Abd E; Roberts MS; Grice JE Skin Pharmacol Physiol; 2016; 29(1):24-30. PubMed ID: 26540487 [TBL] [Abstract][Full Text] [Related]
8. Formulation and Evaluation of Organogels Containing Hyaluronan Microparticles for Topical Delivery of Caffeine. Simsolo EE; Eroğlu İ; Tanrıverdi ST; Özer Ö AAPS PharmSciTech; 2018 Apr; 19(3):1367-1376. PubMed ID: 29380282 [TBL] [Abstract][Full Text] [Related]
9. Synergistic effect of iontophoresis and chemical enhancers on transdermal permeation of tolterodine tartrate for the treatment of overactive bladder. Prasanthi D; Lakshmi PK Int Braz J Urol; 2013; 39(1):63-75; discussion 76. PubMed ID: 23489517 [TBL] [Abstract][Full Text] [Related]
10. Effects of caffeine and siloxanetriol alginate caffeine, as anticellulite agents, on fatty tissue: histological evaluation. Velasco MV; Tano CT; Machado-Santelli GM; Consiglieri VO; Kaneko TM; Baby AR J Cosmet Dermatol; 2008 Mar; 7(1):23-9. PubMed ID: 18254807 [TBL] [Abstract][Full Text] [Related]
11. Nanostructured Non-Ionic Surfactant Carrier-Based Gel for Topical Delivery of Desoximetasone. Shah P; Goodyear B; Dholaria N; Puri V; Michniak-Kohn B Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546426 [TBL] [Abstract][Full Text] [Related]
12. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin. Nair A; Vyas H; Shah J; Kumar A Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811 [TBL] [Abstract][Full Text] [Related]
13. Niosomal gel for site-specific sustained delivery of anti-arthritic drug: in vitro-in vivo evaluation. Kaur K; Jain S; Sapra B; Tiwary AK Curr Drug Deliv; 2007 Oct; 4(4):276-82. PubMed ID: 17979648 [TBL] [Abstract][Full Text] [Related]
14. A two-center, assessor-blinded, prospective trial evaluating the efficacy of a novel hypertonic draining cream for cellulite reduction: A Clinical and instrumental (Antera 3D CS) assessment. Puviani M; Tovecci F; Milani M J Cosmet Dermatol; 2018 Jun; 17(3):448-453. PubMed ID: 29205802 [TBL] [Abstract][Full Text] [Related]
15. Design and development of insulin emulgel formulation for transdermal drug delivery and its evaluation. Akram M; Naqvi SB; Khan A Pak J Pharm Sci; 2013 Mar; 26(2):323-32. PubMed ID: 23455203 [TBL] [Abstract][Full Text] [Related]
16. Effect of iontophoresis and permeation enhancers on the permeation of an acyclovir gel. Vaghani SS; Gurjar M; Singh S; Sureja S; Koradia S; Jivani NP; Patel MM Curr Drug Deliv; 2010 Oct; 7(4):329-33. PubMed ID: 20695844 [TBL] [Abstract][Full Text] [Related]
17. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. Gupta M; Goyal AK; Paliwal SR; Paliwal R; Mishra N; Vaidya B; Dube D; Jain SK; Vyas SP J Liposome Res; 2010 Dec; 20(4):341-50. PubMed ID: 20163329 [TBL] [Abstract][Full Text] [Related]
18. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl. Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964 [TBL] [Abstract][Full Text] [Related]
19. Transdermal enhancement through rat skin of luciferase plasmid DNA loaded in elastic nanovesicles. Manosroi A; Khositsuntiwong N; Götz F; Werner RG; Manosroi J J Liposome Res; 2009; 19(2):91-8. PubMed ID: 19241277 [TBL] [Abstract][Full Text] [Related]
20. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability. Padamwar MN; Pokharkar VB Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]